World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
116
Citations
72977
World Ranking
662
National Ranking
400

Medicine

D-Index
116
Citations
73259
World Ranking
4270
National Ranking
2333

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Robyn J. Barst was a researcher affiliated with Columbia University in the United States, focusing primarily on medicine with a specialization in pulmonary and respiratory medicine. Their research contributions extended into subfields including epidemiology and genetics.

The main topics addressed in their work included pulmonary hypertension research and treatments, congenital heart disease studies, and hemoglobinopathies and related disorders.

Barst's scholarly output included several publications, with notable papers such as:

  • Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry, 2023, published in European Heart Journal - Quality of Care and Clinical Outcomes
  • Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension, 2021, published in UNC Libraries
  • Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies, 2020, published in UNC Libraries

The venues where Barst most frequently published included:

  • UNC Libraries
  • European Heart Journal - Quality of Care and Clinical Outcomes

Barst collaborated regularly with a group of co-authors, which included:

  • D. Dunbar Ivy
  • Maurice Beghetti
  • Damien Bonnet
  • Dursun Alehan
  • László Ablonczy

Best Publications

  • Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry

    Gilbert E. D'Alonzo;Robyn J. Barst;Stephen M. Ayres;Edward H. Bergofsky

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Bosentan therapy for pulmonary arterial hypertension.

    Lewis J. Rubin;David B. Badesch;Robyn J. Barst;Nazzareno Galiè

  • A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Robyn J. Barst;Lewis J. Rubin;Walker A. Long;Michael D. McGoon

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

    Gerald Simonneau;Robyn J. Barst;Nazzareno Galie;Robert Naeije

  • Predicting Survival in Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

    Raymond L. Benza;Dave P. Miller;Mardi Gomberg-Maitland;Robert P. Frantz

  • Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

    Nazzareno Galiè;Adam Torbicki;Robyn Barst;Philippe Dartevelle

  • Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

    Zemin Deng;Jane H. Morse;Susan L. Slager;Nieves Cuervo

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Right Ventricular Function and Failure Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure

    Norbert F. Voelkel;Robert A. Quaife;Leslie A. Leinwand;Robyn J. Barst

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Diagnosis and differential assessment of pulmonary arterial hypertension

    Robyn J Barst;Michael McGoon;Adam Torbicki;Olivier Sitbon

  • Pulmonary Arterial Hypertension : Baseline Characteristics From the REVEAL Registry

    David B. Badesch;Gary E. Raskob;C. Greg Elliott;Abby M. Krichman

  • Tadalafil Therapy for Pulmonary Arterial Hypertension

    Nazzareno Galiè;Bruce H. Brundage;Hossein A. Ghofrani;Ronald J. Oudiz

  • Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines

    David B. Badesch;Steve H. Abman;Gregory S. Ahearn;Robyn J. Barst

  • An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

    Raymond L. Benza;Dave P. Miller;Robyn J. Barst;David B. Badesch

  • Sitaxsentan therapy for pulmonary arterial hypertension

    Robyn J. Barst;David Langleben;Adaani Frost;Evelyn M. Horn

  • Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

    Steven H. Abman;Georg Hansmann;Stephen L. Archer;D. Dunbar Ivy

  • Bosentan therapy for pulmonary arterial hypertension

    L.J. Rubin;D.B. Badesch;R.J. Barst

Frequent Co-Authors

David B. Badesch
David B. Badesch University of Colorado Denver
D. Dunbar Ivy
D. Dunbar Ivy University of Colorado Denver
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Nazzareno Galiè
Nazzareno Galiè University of Bologna
Victor F. Tapson
Victor F. Tapson Duke University
Mark T. Gladwin
Mark T. Gladwin University of Pittsburgh
Gregory J. Kato
Gregory J. Kato CSL Behring
Victor R. Gordeuk
Victor R. Gordeuk University of Illinois at Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways into the medical field can open a variety of rewarding careers whether or not you pursue a full medical degree. For registered nurses looking to advance their clinical expertise, the easiest dnp program online options provide flexibility to earn a doctorate and qualify for high-level roles.

If you want to start working quickly, a fast lpn program can help you become a Licensed Practical Nurse in a shorter time, offering a direct route into patient care positions.

Mental health careers are also in high demand. Those with an MSN can specialize further by enrolling in an msn to pmhnp online program, preparing for specialized roles as a Psychiatric Mental Health Nurse Practitioner.

For those drawn to leadership roles, consider the best online mha programs to gain expertise in healthcare administration and management. These programs equip you to lead healthcare teams and innovate the delivery of medical services.

Best Scientists Citing Robyn J. Barst